Eris Lifesciences Ltd (BOM:540596)
₹ 1367.75 43.05 (3.25%) Market Cap: 186.16 Bil Enterprise Value: 211.04 Bil PE Ratio: 53.47 PB Ratio: 6.71 GF Score: 95/100

Q3 2020 Eris Lifesciences Ltd Earnings Call Transcript

Feb 14, 2020 / 11:00AM GMT
Release Date Price: ₹466 (-11.06%)
Operator

Ladies and gentlemen, good day, and welcome to the Q3 FY '20 Results Conference Call of Eris Lifesciences. This conference call may contain forward-looking statements about the company, which are based on the beliefs, opinions and expectations of the company as on date of this call. These statements are not guarantees of future performance and involve risks and uncertainties that are difficult to predict. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Mr. Amit Bakshi, Chairman and Managing Director of the company. Thank you, and over to you, sir.

Amit Indubhushan Bakshi
Eris Lifesciences Limited - Chairman & MD

Thank you. Good evening, everybody, and welcome to the quarter 3 '20 earnings call. Let me take you through the presentation, and then we will open after for Q&A. The first slide in our presentation talks about a very momentous period for us. As you are aware, in the last call, I told you that we have initiated a study called India Heart Study. It got mentioned in nothing

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot